9 Meters Biopharma Announces Allowance of Patent for NM-102 in Combination with Immune Checkpoint Inhibitors

3 years ago

RALEIGH, NC / ACCESSWIRE / January 24, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments…

Novamind Announces CAD$5 Million Private Placement with Institutional Investor

3 years ago

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, ON / ACCESSWIRE / January 24,…

NeoGenomics First to Partner with Biomarker Collaborative and Deliver Patient Resources Along with Oncology Testing Results

3 years ago

The partnership makes it possible for patients with specific biomarkers to get early supportFT. MYERS, FL / ACCESSWIRE / January…

Panacea Life Sciences, Inc. Announces Exclusive Partnership with Amazon Platform Partner Bright Ideas Unlimited, LLC

3 years ago

GOLDEN, CO / ACCESSWIRE / January 24, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), (the "Company"), a cGMP certified, vertically…

Castellum, Inc. Announces Lieutenant General Bernard S. Champoux, U.S. Army, Retired to Join Advisory Board

3 years ago

Castellum, Inc. Announces Lieutenant General Bernard S. Champoux, U.S. Army, Retired to Join Advisory Board Castellum, Inc. (OTC: ONOV) announces…

Sorrento Receives Purchase Order for 10 Million Covistix Tests From Its Subsidiary Sorrento Mexico for February Delivery in Mexico

3 years ago

As COVID-19 cases spike in Mexico, Sorrento Therapeutics Mexico (“Sorrento Mexico”) won the first tender offer in 2022 by the…

Ayujoy Herbals Ltd. Announces Launch Of It’s Product Immunojoy

3 years ago

• Immunojoy” is a 100% natural, sugar free, gluten free herbal supplement with no additives. • Immunojoy boosts natural immunity…

Chiesi USA, Inc. Receives Top Employer in the U.S. Certification for 2022

3 years ago

Chiesi USA celebrates seven consecutive years of recognition from the Top Employers InstituteCARY, N.C., Jan. 24, 2022 (GLOBE NEWSWIRE) --…

Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI Meeting

3 years ago

Interim data presented in poster reflects median overall survival of 12.0 months, not yet final, and an objective response rate…

RemSleep Holdings Inc Announces Engagement of New Investor Relations Firm and News Distributor

3 years ago

Tampa, FL, Jan. 24, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to…